Saturday 17 October 2026 Export CLDX’s income statement to Excel — free account

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 million, down 78.0% from fiscal 2024. In the quarter to June 2026, revenue fell 96.8%, EPS fell 10.6% and free cash flow fell 35.5%, each against the same quarter a year earlier.

27.53 1.40 −4.84%

Follow CLDX

Alert me

Market cap: $2.3B
P/E: 0.0×
Fwd P/E: −6.6×
Dividend yield: —
F-score: 2/9
Altman Z: 14.41
Beneish M: 6.76
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(43.88%)	(48.94%)	(40.62%)	(32.44%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	2	2	2	—
ROA Full definition →	(40.76%)	(45.36%)	(37.63%)	(30.51%)
ROIC Full definition →	0.00%	(4,051.27%)	(1,828.59%)	(1,057.79%)
Return on Tangible Assets Full definition →	(44.63%)	(68.32%)	(52.91%)	(39.90%)
Average Days of Receivables Full definition →	94.64	53.81	270.40	0.00
Free Cash Flow per Share Full definition →	(3.11)	(3.40)	(3.22)	(2.74)
Free Cash Flow Full definition →	(242.10)	(226.25)	(213.66)	(181.67)
Capital Expenditures Full definition →	(6.54)	(4.09)	(2.71)	(2.19)
Other line items
Cash ROIC Full definition →	(16.89%)	(24.93%)	(20.41%)	(15.38%)
Accounts Receivable Turnover Full definition →	5.54	2.41	2.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	31,432.58%	17,016.73%	9,010.07%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	5,318.94%	2,850.45%	1,611.69%	0.00%
Share Based Compensation of Revenue Full definition →	3,905.41%	2,270.77%	1,331.51%	0.00%
Operating CF/Net income Full definition →	0.78	0.78	0.82	0.80
Depreciation/Fixed assets Full definition →	(0.09)	(0.12)	(0.46)	(1.03)
Capex/Depreciation Full definition →	7.86	4.80	1.10	0.44
Revenue per Share Full definition →	0.01	0.02	0.04	0.00
Operating CF per Share Full definition →	(3.03)	(3.34)	(3.18)	(2.70)
Capex per Share Full definition →	(0.08)	(0.06)	(0.04)	(0.03)
Capex to Sales Full definition →	7.37	2.62	1.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly